<DOC>
	<DOCNO>NCT00824421</DOCNO>
	<brief_summary>This 96 week study determine UK- 453,061 combination Truvada efficacious , safe tolerable efavirenz combination Truvada HIV-1 infect patient previously treat antiretroviral drug .</brief_summary>
	<brief_title>A Study Of Different Doses Of UK-453 , 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1</brief_title>
	<detailed_description />
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Male female least 18 year age available followup period least 96 week . HIV 1 RNA viral load great 1,000 copies/mL Negative urine pregnancy test . Suspected document active , untreated HIV1 related opportunist infection condition require acute therapy time randomization . Subjects acute Hepatitis B and/or C within 30 day randomization . Absolute CD4 count &lt; 200 cells/mm3 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>HIV-1 . Treatment Naive</keyword>
	<keyword>HIV Infections</keyword>
	<keyword>treatment naive</keyword>
</DOC>